Intelligent Bio Solutions Inc. SEC filings INBS

Intelligent Bio Solutions Inc. has 467 filings in SEC EDGAR's recent list, going back to Dec 29, 2017. Its latest annual report, Form ARS, was filed on Nov 2, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 13, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (bylaw or fiscal year change, regulation fd disclosure). The company's fiscal year ends on June 30.

Intelligent Bio Solutions Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Nov 2, 2026 Jun 30, 2026
10-K/A Amended annual report Oct 21, 2026 Jun 30, 2026
10-K Annual report Aug 19, 2026 Jun 30, 2026
ARS Annual report to shareholders Sep 19, 2025 Jun 30, 2025
10-K Annual report Aug 15, 2025 Jun 30, 2025
ARS Annual report to shareholders Apr 1, 2025 Jun 30, 2024
10-K/A Amended annual report Feb 13, 2025 Jun 30, 2024
10-K Annual report Sep 18, 2024 Jun 30, 2024
ARS Annual report to shareholders Nov 16, 2023 Jun 30, 2023
10-K Annual report Aug 23, 2023 Jun 30, 2023
10-K/A Amended annual report Mar 6, 2023 Jun 30, 2022
10-K/A Amended annual report Oct 7, 2022 Jun 30, 2022
10-K Annual report Sep 22, 2022 Jun 30, 2022
10-K/A Amended annual report Sep 30, 2021 Jun 30, 2021
10-K Annual report Sep 16, 2021 Jun 30, 2021

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
INBS (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1725430
Former names
GBS Inc. (until Oct 18, 2022); Glucose Biosensor Systems (Greater China) Holdings, Inc. (until Sep 19, 2019)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.